Investor statement Covid-19

We are writing you on behalf of a large and diverse group of investors who are shareholders and bondholders in a number of pharmaceutical companies. As investors with over EUR 1900 billion in assets under management, we believe that the pharmaceutical sector has a pivotal role to play in providing effective solutions for COVID-19 in a productive and responsible way